David Weinberg

Title: David Weinberg: Innovator in Methylation Sequencing Technology

Introduction

David Weinberg is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of molecular biology, particularly in the area of methylation sequencing. His work focuses on improving the quality and accuracy of nucleic acid methylation sequencing, which is crucial for disease detection.

Latest Patents

David Weinberg holds a patent titled "Methods and systems for high-depth sequencing of methylated nucleic acid." This patent addresses the limitations of bisulfite-based methylation sequencing by introducing methods that enhance the quality and accuracy of nucleic acid methylation sequencing. The innovations include minimally-destructive conversion methods and specialized UMI adapters, which lead to improved sequencing libraries and information. The advancements allow for greater accuracy and more complete methylation-state information, facilitating higher quality feature generation for machine learning models and classifier generation. He has 1 patent to his name.

Career Highlights

David Weinberg is currently associated with Freenome Holdings, Inc., where he applies his expertise in developing cutting-edge technologies for health diagnostics. His work at Freenome focuses on leveraging advanced sequencing methods to enhance disease detection capabilities.

Collaborations

David collaborates with various professionals in the field, including his coworker Greg Hogan. Their combined efforts contribute to the advancement of innovative solutions in methylation sequencing.

Conclusion

David Weinberg's contributions to the field of methylation sequencing represent a significant advancement in molecular biology. His innovative methods and systems are paving the way for improved disease detection and diagnostics.